| Members |
acceptabilityId |
| pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) (finding) |
Preferred (foundation metadata concept) |
| pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) |
Preferred (foundation metadata concept) |
| pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) (finding) |
Preferred (foundation metadata concept) |
| pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) |
Preferred (foundation metadata concept) |
| pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) (finding) |
Preferred (foundation metadata concept) |
| pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) |
Preferred (foundation metadata concept) |
| pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) (finding) |
Preferred (foundation metadata concept) |
| pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) |
Preferred (foundation metadata concept) |
| pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) (finding) |
Preferred (foundation metadata concept) |
| pT3 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) |
Preferred (foundation metadata concept) |
| pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) (finding) |
Preferred (foundation metadata concept) |
| pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) |
Preferred (foundation metadata concept) |
| pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) (finding) |
Preferred (foundation metadata concept) |
| pT3 category |
Preferred (foundation metadata concept) |
| pT3 category (finding) |
Preferred (foundation metadata concept) |
| pT3 stage |
Acceptable (foundation metadata concept) |
| pT3: Discontinuous tumors in the primary bone site (bone) |
Preferred (foundation metadata concept) |
| pT3: Discontinuous tumors in the primary bone site (bone) (finding) |
Preferred (foundation metadata concept) |
| pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing sarcoma) |
Acceptable (foundation metadata concept) |
| pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) |
Preferred (foundation metadata concept) |
| pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding) |
Preferred (foundation metadata concept) |
| pT3: Extraprostatic extension (prostate) |
Preferred (foundation metadata concept) |
| pT3: Extraprostatic extension (prostate) (finding) |
Preferred (foundation metadata concept) |
| pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) |
Preferred (foundation metadata concept) |
| pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding) |
Preferred (foundation metadata concept) |
| pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) |
Preferred (foundation metadata concept) |
| pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) (finding) |
Preferred (foundation metadata concept) |
| pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) |
Preferred (foundation metadata concept) |
| pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor >5 cm in greatest dimension (breast) |
Acceptable (foundation metadata concept) |
| pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) |
Preferred (foundation metadata concept) |
| pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) |
Preferred (foundation metadata concept) |
| pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota fascia (kidney) |
Acceptable (foundation metadata concept) |
| pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) |
Preferred (foundation metadata concept) |
| pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) |
Preferred (foundation metadata concept) |
| pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) |
Preferred (foundation metadata concept) |
| pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades adventitia (esophagus) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades adventitia (esophagus) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades beyond muscularis into periureteric fat (ureter) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades beyond muscularis into periureteric fat (ureter) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades pancreas (ampulla of Vater) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades pancreas (ampulla of Vater) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades perivesical tissue (urinary bladder) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades perivesical tissue (urinary bladder) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine) |
Preferred (foundation metadata concept) |
| pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma) |
Preferred (foundation metadata concept) |
| pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma) |
Acceptable (foundation metadata concept) |
| pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor involves bony structures and/or paranasal sinuses (nasopharynx) |
Preferred (foundation metadata concept) |
| pT3: Tumor involves bony structures and/or paranasal sinuses (nasopharynx) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor limited to larynx with vocal cord fixation (larynx, subglottis) |
Preferred (foundation metadata concept) |
| pT3: Tumor limited to larynx with vocal cord fixation (larynx, subglottis) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor limited to the larynx with vocal cord fixation and/or invades any of the following: postcrocoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (e.g., inner cortex) (larynx, supraglottis) |
Preferred (foundation metadata concept) |
| pT3: Tumor limited to the larynx with vocal cord fixation and/or invades any of the following: postcrocoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (e.g., inner cortex) (larynx, supraglottis) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor limited to the larynx with vocal cord fixation, and/or invades the paraglottic space, and/or minor thyroid cartilage erosion (larynx, glottis) |
Preferred (foundation metadata concept) |
| pT3: Tumor limited to the larynx with vocal cord fixation, and/or invades the paraglottic space, and/or minor thyroid cartilage erosion (larynx, glottis) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx (hypopharynx) |
Preferred (foundation metadata concept) |
| pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx (hypopharynx) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) without extraocular extension (ciliary body and choroid) (uveal melanoma) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) without extraocular extension (ciliary body and choroid) (uveal melanoma) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension (major salivary glands) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension (major salivary glands) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 4 cm in greatest dimension (lip and oral cavity) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 4 cm in greatest dimension (lip and oral cavity) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 4 cm in greatest dimension (oropharynx) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 4 cm in greatest dimension (oropharynx) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) (thyroid) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) (thyroid) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 5 cm in greatest dimension (anal canal) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 5 cm in greatest dimension (anal canal) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 5 cm in greatest dimension (breast) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 5 cm in greatest dimension (breast) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Preferred (foundation metadata concept) |
| pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures (stomach) |
Preferred (foundation metadata concept) |
| pT3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures (stomach) (finding) |
Preferred (foundation metadata concept) |
| pT3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts (gallbladder) |
Preferred (foundation metadata concept) |
| pT3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts (gallbladder) (finding) |
Preferred (foundation metadata concept) |
| pT3:Tumor directly invades any of following:chest wall,diaphragm,mediastinal pleura,parietal pericardium;or tumor in main bronchus<2 cm distal to carina(not involving it);or assoc atelectasis or obstructive pneumonitis of whole lung |
Preferred (foundation metadata concept) |
| pT3:Tumor directly invades any of following:chest wall,diaphragm,mediastinal pleura,parietal pericardium;or tumor in main bronchus<2 cm distal to carina(not involving it);or assoc atelectasis or obstructive pneumonitis of whole lung (finding) |
Preferred (foundation metadata concept) |
FHIR